138 related articles for article (PubMed ID: 38426242)
1. Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology.
Calleris G; von Deimling M; Kesch C; Soria F; Gontero P; Ploussard G; Laukhtina E; Pradere B
Curr Opin Urol; 2024 May; 34(3):217-224. PubMed ID: 38426242
[TBL] [Abstract][Full Text] [Related]
2. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for metastasis-directed therapy in bladder cancer?
Abufaraj M; Al Karmi J; Bdeir A
Curr Opin Urol; 2024 Jul; 34(4):273-280. PubMed ID: 38587010
[TBL] [Abstract][Full Text] [Related]
4. Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review.
Li R; Metcalfe M; Kukreja J; Navai N
Bladder Cancer; 2018 Jan; 4(1):31-40. PubMed ID: 29430505
[TBL] [Abstract][Full Text] [Related]
5. Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.
Aboudaram A; Chaltiel L; Pouessel D; Graff-Cailleaud P; Benziane-Ouaritini N; Sargos P; Schick U; Créhange G; Cohen-Jonathan Moyal E; Chevreau C; Khalifa J
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831503
[TBL] [Abstract][Full Text] [Related]
6. [Locally advanced or oligometastatic bladder cancer-role of local treatment of the primary tumor and metastases].
Rebhan K; Gust KM
Urologe A; 2021 Dec; 60(12):1555-1560. PubMed ID: 34825935
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
Slaoui A; Albisinni S; Aoun F; Assenmacher G; Al Hajj Obeid W; Diamand R; Regragui S; Touzani A; Bakar A; Mesfioui A; Karmouni T; Ameur A; Elkhader K; Koutani A; Ibnattya A; Roumeguere T; Peltier A
World J Urol; 2019 Nov; 37(11):2343-2353. PubMed ID: 30706122
[TBL] [Abstract][Full Text] [Related]
8. Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty.
Bamias A; Stenzl A; Brown SL; Albiges L; Babjuk M; Birtle A; Briganti A; Burger M; Choudhury A; Colecchia M; De Santis M; Fanti S; Fonteyne V; Gallucci M; Rivas JG; Huddart R; Junker K; Kroeze S; Loriot Y; Merseburger A; Montironi R; Necchi A; Oing C; Oldenburg J; Ost P; Pinkawa M; Ribal MJ; Rouprêt M; Thoeny H; Zilli T; Hoskin P
Eur Urol; 2023 Oct; 84(4):381-389. PubMed ID: 37217391
[TBL] [Abstract][Full Text] [Related]
9. Metastasis-Directed Radiation Therapy with Consolidative Intent for Oligometastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Longo N; Celentano G; Napolitano L; La Rocca R; Capece M; Califano G; Collà Ruvolo C; Mangiapia F; Fusco F; Morra S; Turco C; Di Bello F; Fusco GM; Cirillo L; Cacciapuoti C; Spirito L; Calogero A; Sica A; Sagnelli C; Creta M
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625979
[TBL] [Abstract][Full Text] [Related]
10. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.
Kent CL; McDuff SGR; Salama JK
Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer.
De Bleser E; Tran PT; Ost P
Curr Opin Urol; 2017 Nov; 27(6):587-595. PubMed ID: 28816714
[TBL] [Abstract][Full Text] [Related]
12. Defining Oligometastatic Bladder Cancer: A Systematic Review.
Bamias A; Stenzl A; Zagouri F; Andrikopoulou A; Hoskin P
Eur Urol Open Sci; 2023 Sep; 55():28-37. PubMed ID: 37662704
[TBL] [Abstract][Full Text] [Related]
13. Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer-A Systematic Review.
de Barros HA; van Beurden I; Droghetti M; Wilthagen EA; Özman O; Bergman AM; Aluwini S; van Moorselaar RJA; Donswijk ML; van Leeuwen PJ; van der Poel HG
Eur Urol Oncol; 2023 Feb; 6(1):16-27. PubMed ID: 36372736
[TBL] [Abstract][Full Text] [Related]
14. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.
Glicksman RM; Metser U; Vines D; Valliant J; Liu Z; Chung PW; Bristow RG; Finelli A; Hamilton R; Fleshner NE; Perlis N; Zlotta AR; Green D; Bayley A; Helou J; Raman S; Kulkarni G; Catton C; Lam T; Chan R; Warde P; Gospodarowicz M; Jaffray DA; Berlin A
Eur Urol; 2021 Sep; 80(3):374-382. PubMed ID: 33685838
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy.
Milenkovic U; Kuijk J; Roussel E; Devos G; Van den Broeck T; Van Eecke H; Vanderstichele A; Duvillier T; Verhamme L; Van Haute W; Goeman L; Berghen C; Joniau S; De Meerleer G
Eur Urol Oncol; 2023 Dec; 6(6):582-589. PubMed ID: 36878753
[TBL] [Abstract][Full Text] [Related]
17. Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials.
Connor MJ; Smith A; Miah S; Shah TT; Winkler M; Khoo V; Ahmed HU
Eur Urol Oncol; 2020 Oct; 3(5):582-593. PubMed ID: 32891600
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies.
Miszczyk M; Rajwa P; Yanagisawa T; Nowicka Z; Shim SR; Laukhtina E; Kawada T; von Deimling M; Pradere B; Rivas JG; Gandaglia G; van den Bergh RCN; Goldner G; Supiot S; Zilli T; Trinh QD; Nguyen PL; Briganti A; Ost P; Ploussard G; Shariat SF
Eur Urol; 2024 Feb; 85(2):125-138. PubMed ID: 37945451
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes of metastasis-directed treatment using
Hurmuz P; Onal C; Ozyigit G; Igdem S; Atalar B; Sayan H; Akgun Z; Kurt M; Ozkok HB; Selek U; Oymak E; Tilki B; Guler OC; Mustafayev TZ; Saricanbaz I; Rzazade R; Akyol F
Strahlenther Onkol; 2020 Nov; 196(11):1034-1043. PubMed ID: 32617620
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies.
Franzese C; Francolini G; Nicosia L; Alongi F; Livi L; Scorsetti M
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):50-56. PubMed ID: 32723486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
